Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  2006-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1472-8206.2006.00449.xPMID 17109653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide

  2021cited by this paper
• Neuronal death/survival signaling pathways in cerebral ischemia

  2011cited by this paper
• Activation of protein kinase A improves vascular endothelial dysfunction.

  2006cited by this paper
• Involvement of Rho-kinase in experimental vascular endothelial dysfunction

  2006cited by this paper
• HYPERINSULINAEMIA INCREASES THE GENE EXPRESSION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE AND THE PHOSPHATIDYLINOSITOL 3‐KINASE/AKT PATHWAY IN RAT AORTA

  2006cited by this paper
• NADPH oxidase and endothelial cell function.

  2005cited by this paper
• Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.

  2005cited by this paper
• The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

  2004cited by this paper
• Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction.

  2004cited by this paper
• Colocalization of eNOS and the Catalytic Subunit of PKA in Endothelial Cell Junctions: A Clue for Regulated NO Production

  2004cited by this paper
• System-specific O2 sensitivity of the tandem pore domain K+ channel TASK-1.

  2004cited by this paper
• Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles.

  2004cited by this paper
• Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning.

  2004cited by this paper
• Direct Interaction of the Novel Nox Proteins with p22phox Is Required for the Formation of a Functionally Active NADPH Oxidase*

  2004cited by this paper
• Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein.

  2003cited by this paper
• PKC activates BKCa channels in rat pulmonary arterial smooth muscle via cGMP-dependent protein kinase.

  2003cited by this paper
• Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-&kgr;B Induced by Oxidative Stress

  2003cited by this paper
• PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction.

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase.

  2003cited by this paper
• Endothelium-dependent effects of statins.

  2003cited by this paper
• Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

  2003cited by this paper
• ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents.

  2003cited by this paper
• Vasopressin Induces Vascular Superoxide Via Endothelin-1 in Mineralocorticoid Hypertension

  2003cited by this paper
• Endothelium : Signaling , Oxidative Stress , and Gene Expression

  2003cited by this paper
• NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?

  2002cited by this paper
• Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy.

  2002cited by this paper
• The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase.

  2002cited by this paper
• cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions

  2002cited by this paper
• Upregulation of Nox‐Based NAD(P)H Oxidases in Restenosis After Carotid Injury

  2002cited by this paper
• Statin Prevents Tissue Factor Expression in Human Endothelial Cells: Role of Rho/Rho-Kinase and Akt Pathways

  2002cited by this paper
• Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells

  2002cited by this paper
• Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)‐induced microvascular permeability change in mouse skin

  2001cited by this paper
• Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

  2001cited by this paper
• cAMP Signal Transduction Cascade, a Novel Pathway for the Regulation of Endothelial Nitric Oxide Production in Coronary Blood Vessels

  2001cited by this paper
• Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

  2001cited by this paper
• 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells.

  2001cited by this paper
• Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways

  2001cited by this paper
• 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells

  2001cited by this paper
• Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists

  2001cited by this paper
• Nitric oxide in the pathogenesis of vascular disease

  2000cited by this paper
• Endothelial dysfunction in diabetes

  2000cited by this paper
• Regulation of Cardiac L-Type Calcium Channels by Protein Kinase A and Protein Kinase C

  2000cited by this paper
• Mechanism of Protein Kinase B Activation by Cyclic AMP-Dependent Protein Kinase

  1999cited by this paper
• Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits.

  1999cited by this paper
• Expression of NADH/NADPH oxidase p22phox in human coronary arteries.

  1999cited by this paper
• Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide‐induced inflammation in mouse lung

  1998cited by this paper
• A family of cAMP-binding proteins that directly activate Rap1.

  1998cited by this paper
• Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta

  1998cited by this paper
• Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase*

  1998cited by this paper
• Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy.

  1998cited by this paper
• The signal transduction mechanism involved in kazinol B‐stimulated superoxide anion generation in rat neutrophils

  1998cited by this paper
• Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

  1997cited by this paper
• p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.

  1997cited by this paper
• The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension.

  1997cited by this paper
• p22phox Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle Cells*

  1996cited by this paper
• Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram

  1996cited by this paper
• L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil.

  1995cited by this paper
• Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.

  1988cited by this paper
• Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

  1977cited by this paper
• Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity.

  1974cited by this paper

• Barbatic acid inhibits inflammatory responses and endothelial dysfunction in hypertension by regulating HIF1A/FLT1 pathway: A computer-aided biolabel research and experimental validation

  2025cites this paper
• Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.

  2019cites this paper
• Natriuretic peptide receptor-C activation regulates vascular smooth muscle cell hypertrophy : molecular mechanisms

  2017cites this paper
• Animal Models of Disease for Future Toxicity Predictions

  2016cites this paper
• Rodent animal models: from mild to advanced stages of diabetic nephropathy

  2014cites this paper
• A standardized extract of the fruit of Ziziphus jujuba (Jujube) induces neuronal differentiation of cultured PC12 cells: a signaling mediated by protein kinase A.

  2014cites this paper
• The role of nitric oxide on endothelial function.

  2012cites this paper
• Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.

  2011cites this paper
• The Defensive Effect of Benfotiamine in Sodium Arsenite-Induced Experimental Vascular Endothelial Dysfunction

  2010cites this paper
• The role of intracellular 3'5'-cyclic adenosine monophosphate (cAMP) in atherosclerosis.

  2010cites this paper
• Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats

  2010cites this paper
• Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions.

  2008influential citation
• Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes

  2008cites this paper
• Pharmacological Interventions to Prevent Vascular Endothelial Dysfunction: Future Directions

  2008cites this paper
• Effect of cyclic 3', 5' adenosin-monophosphate on osteogenesis embryonic bone cultivated in tissue culture: an autoradiographic study.

  2007cites this paper
• C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.

  2007cites this paper
• Mechanisms of soy isoflavones in the regulation of vascular function

  2007cites this paper